The Candida albicans toxin candidalysin mediates distinct epithelial inflammatory responses through p38 and EGFR-ERK pathways DOI
Spyridoula-Angeliki Nikou, Chunsheng Zhou, James S. Griffiths

и другие.

Science Signaling, Год журнала: 2022, Номер 15(728)

Опубликована: Апрель 5, 2022

The fungal pathogen

Язык: Английский

Oral potentially malignant disorders: A consensus report from an international seminar on nomenclature and classification, convened by the WHO Collaborating Centre for Oral Cancer DOI
Saman Warnakulasuriya, Omar Kujan, José M. Aguirre‐Urizar

и другие.

Oral Diseases, Год журнала: 2020, Номер 27(8), С. 1862 - 1880

Опубликована: Окт. 31, 2020

Oral potentially malignant disorders (OPMDs) are associated with an increased risk of occurrence cancers the lip or oral cavity. This paper presents updated report on nomenclature and classification OPMDs, based predominantly their clinical features, following discussions by expert group at a workshop held World Health Organization (WHO) Collaborating Centre for Cancer in UK. The first London 2005 considered wide spectrum under term "potentially mucosa" (PMD) (now referred to as disorders: OPMD) including leukoplakia, erythroplakia, proliferative verrucous lichen planus, submucous fibrosis, palatal lesions reverse smokers, lupus erythematosus, epidermolysis bullosa, dyskeratosis congenita. Any new evidence published intervening period was make essential changes 2007 classification. In current update, most entities were retained minor definition. There is sufficient cancer among patients diagnosed "oral lichenoid lesions" those manifestations 'chronic graft-versus-host disease'. These have now been added list OPMDs. is, date, insufficient concerning potential chronic hyperplastic candidosis exophytic hyperplasia consider these conditions Furthermore, due lack clear OPMD bullosa this moved category limited evidence. We recommend establishment global research consortium further study natural history OPMDs proposed here. will require multi-center longitudinal studies uniform diagnostic criteria improve identification stratification link them evidence-based interventions, goal facilitate prevention management cavity cancer.

Язык: Английский

Процитировано

765

Vulvovaginal Candidiasis: A Current Understanding and Burning Questions DOI Creative Commons

Hubertine M. E. Willems,

Salman Shaheer Ahmed,

Junyan Liu

и другие.

Journal of Fungi, Год журнала: 2020, Номер 6(1), С. 27 - 27

Опубликована: Фев. 25, 2020

Candida albicans, along with other closely related species, are the primary causative agents of vulvovaginal candidiasis (VVC)—a multifactorial infectious disease lower female reproductive tract resulting in pathologic inflammation. Unlike forms candidiasis, VVC is a immunocompetent and otherwise healthy women, most predominant during their child-bearing years. While non-lethal, its high global incidence profound negative impact on quality-of-life necessitates further understanding host fungal factors that drive pathogenesis. In this review, we cover current state our epidemiology, response, pathogenicity mechanisms, microbiome, novel approaches to treatment prevalent human candidal infection. We also offer insight into latest advancements field identify important questions still remain.

Язык: Английский

Процитировано

258

Pathogenesis and virulence of Candida albicans DOI Creative Commons
José Pedro Lopes, Michail S. Lionakis

Virulence, Год журнала: 2021, Номер 13(1), С. 89 - 121

Опубликована: Дек. 29, 2021

is a commensal yeast fungus of the human oral, gastrointestinal, and genital mucosal surfaces, skin. Antibiotic-induced dysbiosis, iatrogenic immunosuppression, and/or medical interventions that impair integrity mucocutaneous barrier perturb protective host defense mechanisms enable

Язык: Английский

Процитировано

258

The impact of the Fungus-Host-Microbiota interplay uponCandida albicansinfections: current knowledge and new perspectives DOI Creative Commons
Christophe d’Enfert,

Ann-Kristin Kaune,

Leovigildo-Rey Alaban

и другие.

FEMS Microbiology Reviews, Год журнала: 2020, Номер 45(3)

Опубликована: Ноя. 18, 2020

Candida albicans is a major fungal pathogen of humans. It exists as commensal in the oral cavity, gut or genital tract most individuals, constrained by local microbiota, epithelial barriers and immune defences. Their perturbation can lead to outgrowth development mucosal infections such oropharyngeal vulvovaginal candidiasis, patients with compromised immunity are susceptible life-threatening systemic infections. The importance interplay between fungus, host microbiota driving transition from C. commensalism pathogenicity widely appreciated. However, complexity these interactions, significant impact fungal, variability upon disease severity outcome, less well understood. Therefore, we summarise features fungus that promote infection, how genetic variation clinical isolates influences pathogenicity. We discuss antifungal immunity, this differs mucosae, individual person's susceptibility infection. Also, describe factors influence composition gut, vaginal microbiotas, affect colonisation immunity. argue detailed understanding variables, which underlie fungal-host-microbiota will present opportunities for directed therapies benefit vulnerable patients.

Язык: Английский

Процитировано

236

Candidalysin: discovery and function in Candida albicans infections DOI Creative Commons
Julian R. Naglik, Sarah L. Gaffen, Bernhard Hube

и другие.

Current Opinion in Microbiology, Год журнала: 2019, Номер 52, С. 100 - 109

Опубликована: Июль 6, 2019

Candidalysin is a cytolytic peptide toxin secreted by the invasive form of human pathogenic fungus, Candida albicans. critical for mucosal and systemic infections key driver host cell activation, neutrophil recruitment Type 17 immunity. regarded as first true classical virulence factor C. albicans but also triggers protective immune responses. This review will discuss how candidalysin was discovered, mechanisms which this contributes to infections, its discovery has advanced our understanding fungal pathogenesis disease.

Язык: Английский

Процитировано

181

Improved pharmacodynamics of epidermal growth factor via microneedles-based self-powered transcutaneous electrical stimulation DOI Creative Commons
Yuan Yang,

Ruizeng Luo,

Shengyu Chao

и другие.

Nature Communications, Год журнала: 2022, Номер 13(1)

Опубликована: Ноя. 14, 2022

Epidermal growth factor is an excellent drug for promoting wound healing; however, its conventional administration strategies are associated with pharmacodynamic challenges, such as low transdermal permeability, reduction, and receptor desensitization. Here, we develop a microneedle-based self-powered transcutaneous electrical stimulation system (mn-STESS) by integrating sliding free-standing triboelectric nanogenerator microneedle patch to achieve improved epidermal pharmacodynamics. We show that the mn-STESS facilitates penetration utilization using microneedles pierce stratum corneum. More importantly, find it converts mechanical energy of finger into electricity mediates through microneedles. demonstrate applied acts "adjuvant" suppresses reduction glutathione upregulates expression in keratinocyte cells, successfully compensating Collectively, this work highlights promise adjuvants improving pharmacodynamics, creating combinatorial therapeutic traditional drugs.

Язык: Английский

Процитировано

116

Intestinal mycobiota in health and diseases: from a disrupted equilibrium to clinical opportunities DOI Creative Commons
Xiaoyan Wu, Yaoyao Xia, Fang He

и другие.

Microbiome, Год журнала: 2021, Номер 9(1)

Опубликована: Март 14, 2021

Abstract Bacteria, viruses, protozoa, and fungi establish a complex ecosystem in the gut. Like other microbiota, gut mycobiota plays an indispensable role modulating intestinal physiology. Notably, most striking characteristics of are their extraintestinal functions. Here, we provide comprehensive review importance regulation intestinal, pulmonary, hepatic, renal, pancreatic, brain functions, present possible opportunities for application to alleviate/treat human diseases.

Язык: Английский

Процитировано

111

Candida albicans and Candida glabrata : global priority pathogens DOI
Myrto Katsipoulaki, Mark H. T. Stappers, Dhara Malavia

и другие.

Microbiology and Molecular Biology Reviews, Год журнала: 2024, Номер 88(2)

Опубликована: Июнь 4, 2024

SUMMARYA significant increase in the incidence of

Язык: Английский

Процитировано

32

The pathobiology of human fungal infections DOI
Gordon D. Brown, Elizabeth R. Ballou, Steven Bates

и другие.

Nature Reviews Microbiology, Год журнала: 2024, Номер 22(11), С. 687 - 704

Опубликована: Июнь 25, 2024

Язык: Английский

Процитировано

28

Fungi, immunosenescence and cancer DOI Creative Commons
Bin Xu,

Zan Luo,

Xing Niu

и другие.

Seminars in Cancer Biology, Год журнала: 2025, Номер 109, С. 67 - 82

Опубликована: Янв. 7, 2025

Язык: Английский

Процитировано

4